Suicidality Screening For All New Drugs Still On The Table After Draft Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA lists eight drug classes where it will recommend prospective assessment of suicidality risk, but it invites comments on broadening the criteria.